JPH0261959B2 - - Google Patents
Info
- Publication number
- JPH0261959B2 JPH0261959B2 JP16062682A JP16062682A JPH0261959B2 JP H0261959 B2 JPH0261959 B2 JP H0261959B2 JP 16062682 A JP16062682 A JP 16062682A JP 16062682 A JP16062682 A JP 16062682A JP H0261959 B2 JPH0261959 B2 JP H0261959B2
- Authority
- JP
- Japan
- Prior art keywords
- ascorbic acid
- phosphate
- activated carbon
- acid
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 49
- 238000000034 method Methods 0.000 claims description 24
- 239000007864 aqueous solution Substances 0.000 claims description 17
- MIJPAVRNWPDMOR-ZAFYKAAXSA-N L-ascorbic acid 2-phosphate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(OP(O)(O)=O)=C1O MIJPAVRNWPDMOR-ZAFYKAAXSA-N 0.000 claims description 12
- 230000002378 acidificating effect Effects 0.000 claims description 6
- 239000003125 aqueous solvent Substances 0.000 claims description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 24
- 239000000243 solution Substances 0.000 description 22
- 239000011148 porous material Substances 0.000 description 21
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 15
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 239000000047 product Substances 0.000 description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- -1 L-ascorbic acid-2-phosphate ester Chemical class 0.000 description 11
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 11
- 238000006366 phosphorylation reaction Methods 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 229960005070 ascorbic acid Drugs 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- 239000002211 L-ascorbic acid Substances 0.000 description 8
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 235000000069 L-ascorbic acid Nutrition 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 235000002639 sodium chloride Nutrition 0.000 description 7
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- 150000003014 phosphoric acid esters Chemical class 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 238000004587 chromatography analysis Methods 0.000 description 5
- 238000004040 coloring Methods 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 235000011121 sodium hydroxide Nutrition 0.000 description 5
- 238000001179 sorption measurement Methods 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- ACFGRWJEQJVZTM-LEJBHHMKSA-L Magnesium L-ascorbic acid-2-phosphate Chemical compound [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])([O-])=O)=C1O ACFGRWJEQJVZTM-LEJBHHMKSA-L 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 4
- 238000002425 crystallisation Methods 0.000 description 4
- 230000008025 crystallization Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 3
- 235000019270 ammonium chloride Nutrition 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 229910001873 dinitrogen Inorganic materials 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 239000000395 magnesium oxide Substances 0.000 description 3
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 3
- 159000000003 magnesium salts Chemical class 0.000 description 3
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 3
- 150000003512 tertiary amines Chemical class 0.000 description 3
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- HHDUMDVQUCBCEY-UHFFFAOYSA-N 4-[10,15,20-tris(4-carboxyphenyl)-21,23-dihydroporphyrin-5-yl]benzoic acid Chemical compound OC(=O)c1ccc(cc1)-c1c2ccc(n2)c(-c2ccc(cc2)C(O)=O)c2ccc([nH]2)c(-c2ccc(cc2)C(O)=O)c2ccc(n2)c(-c2ccc(cc2)C(O)=O)c2ccc1[nH]2 HHDUMDVQUCBCEY-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- 239000004254 Ammonium phosphate Substances 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 2
- 235000019289 ammonium phosphates Nutrition 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 159000000007 calcium salts Chemical class 0.000 description 2
- 239000012295 chemical reaction liquid Substances 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- 230000026731 phosphorylation Effects 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- AFINAILKDBCXMX-PBHICJAKSA-N (2s,3r)-2-amino-3-hydroxy-n-(4-octylphenyl)butanamide Chemical compound CCCCCCCCC1=CC=C(NC(=O)[C@@H](N)[C@@H](C)O)C=C1 AFINAILKDBCXMX-PBHICJAKSA-N 0.000 description 1
- TURWXBQPPKQQIC-UHFFFAOYSA-N 4-[4-(4-oxobutylamino)butylamino]butanal Chemical compound O=CCCCNCCCCNCCCC=O TURWXBQPPKQQIC-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- LLNHIGHHDJZQML-UHFFFAOYSA-N O=O.[P] Chemical compound O=O.[P] LLNHIGHHDJZQML-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000006103 coloring component Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 239000012156 elution solvent Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 239000012476 oxidizable substance Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003015 phosphoric acid halides Chemical class 0.000 description 1
- 230000000865 phosphorylative effect Effects 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
Description
【発明の詳細な説明】
本発明は、L−アスコルビン酸−2−リン酸エ
ステルの精製法に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for purifying L-ascorbic acid-2-phosphate.
L−アスコルビン酸は、医薬品、食品、化粧品
等の分野で広く使用されているが、熱、光に弱
く、被酸化性物質である。そこで、これらの欠点
を除くたに、リン酸エステル体とすると、熱、
光、酸化剤等に対し安定であることが知られ、リ
ン酸エステル体の製造法が種々提案されてきた。 L-ascorbic acid is widely used in the fields of medicine, food, cosmetics, etc., but it is sensitive to heat and light and is an oxidizable substance. Therefore, in addition to eliminating these drawbacks, if we use a phosphoric acid ester,
It is known to be stable against light, oxidizing agents, etc., and various methods for producing phosphoric acid esters have been proposed.
L−アスコルビン酸−2−リン酸エステルは、
L−アスコルビン酸をリン酸化することによつて
得られるが、その反応液中には種々の不純物、た
とえばL−アスコルビン酸の不安定性に基因する
分解物、種々のリン酸化物などが含まれている。
このような反応液中から、目的とするL−アスコ
ルビン酸−2−リン酸エステルを高収量且つ高純
度で得ることは極めて困難であり、既報告の精製
法によつては満足な結果は得られない。 L-ascorbic acid-2-phosphate ester is
It is obtained by phosphorylating L-ascorbic acid, but the reaction solution contains various impurities, such as decomposition products due to the instability of L-ascorbic acid and various phosphoric oxides. There is.
It is extremely difficult to obtain the desired L-ascorbic acid-2-phosphate ester in high yield and purity from such a reaction solution, and previously reported purification methods have not yielded satisfactory results. I can't.
このような情況に鑑み、本発明者らは、精製条
件の検討を種々行なつたところ、活性炭を用い精
製すると高収率かつ高純度でL−アスコルビン酸
−2−リン酸エステルを精製できることを見い出
し、さらに研究した結果、本発明を完成した。 In view of these circumstances, the present inventors conducted various studies on purification conditions and found that L-ascorbic acid-2-phosphate ester can be purified with high yield and high purity when purified using activated carbon. As a result of this discovery and further research, the present invention was completed.
本発明は、L−アスコルビン酸−2−リン酸エ
ステルを含有する強酸性の水容液をカラムにつめ
た活性炭に接触させてL−アスコルビン酸−2−
リン酸エステルを吸着させ、次いで水性溶媒で溶
出することを特徴とするL−アスコルビン酸−2
−リン酸エステルの精製法である。 In the present invention, a strongly acidic aqueous solution containing L-ascorbic acid-2-phosphate is brought into contact with activated carbon packed in a column.
L-ascorbic acid-2 characterized by adsorbing a phosphoric acid ester and then eluting it with an aqueous solvent.
- A method for purifying phosphoric acid esters.
本発明で用いられるL−アスコルビン酸−2−
リン酸エステルを含有する液としては、L−アス
コルビン酸をリン酸化反応に付して得られた2−
リン酸エステルを含有する反応液が挙げられる。
該リン酸化反応は、いずれのリン酸化反応でもよ
い。該反応液としては、たとえば5位および6位
の保護されまたはされないL−アスコルビン酸と
リン酸ハロゲン化物とを特定の溶媒中、塩基の存
在下に室温以下で反応させ、得られるリン酸誘導
体を加水分解して得られた反応液〔特公昭52−
18191号公報、ケミカル・アンド・フアーマシユ
ウテイカル・ビユーレチン(Chemical &
Pharmaceutical Bulletin)第19巻、No.7、第
1433−1437頁(1971年)、同第30巻、No.3、第
1024−1029頁(1982年)参照〕、5,6−0−イ
ソプロピリデン−L−アスコルビン酸、一般式
POX3(X:ハロゲン)および第3級アミンを特
定の溶媒中で混合し、該混合物を少なくとも約8
のPH値に維持し反応させることにより得られた反
応液(特開昭52−136160号公報参照)などが挙げ
られる。 L-ascorbic acid-2- used in the present invention
The liquid containing phosphoric acid ester is 2- obtained by subjecting L-ascorbic acid to a phosphorylation reaction.
A reaction solution containing a phosphoric acid ester can be mentioned.
The phosphorylation reaction may be any phosphorylation reaction. As the reaction solution, for example, L-ascorbic acid with or without protection at the 5- and 6-positions is reacted with a phosphoric acid halide in a specific solvent in the presence of a base at room temperature or below, and the resulting phosphoric acid derivative is Reaction liquid obtained by hydrolysis [Special Publication 1977-
Publication No. 18191, Chemical & Pharmaceutical Biuretin
Pharmaceutical Bulletin) Volume 19, No. 7, No.
pp. 1433-1437 (1971), Volume 30, No. 3, No.
1024-1029 (1982)], 5,6-0-isopropylidene-L-ascorbic acid, general formula
POX 3 (X: halogen) and a tertiary amine are mixed in a specific solvent, and the mixture is
For example, a reaction solution obtained by maintaining the pH value of
本発明方法で用いられるL−アスコルビン酸−
2−リン酸エステルを含有する液としては、上記
の反応液をあらかじめ処理するのがよい。該処理
としては、たとえば使用された溶媒の留去、塩基
あるいは第三級アミンの除去などが挙げられる。 L-ascorbic acid used in the method of the present invention
As the liquid containing 2-phosphoric acid ester, it is preferable to treat the above-mentioned reaction liquid in advance. Examples of such treatments include distilling off the solvent used, removing bases or tertiary amines, and the like.
該溶媒を留去する方法としては、たとえばL−ア
スコルビン酸−2−リン酸エステルの分解を抑え
るために、出来るだけ低温で減圧下に留去する。
該塩基あるいは第3級アミンを除去する方法とし
ては、たとえば該反応液を無機アルカリ(例、水
酸化ナトリウム、水酸化カリウム等)水溶液でPH
を約11以上にし、減圧下で留去する。As a method for distilling off the solvent, for example, in order to suppress decomposition of L-ascorbic acid-2-phosphate, the solvent is distilled off under reduced pressure at as low a temperature as possible.
As a method for removing the base or tertiary amine, for example, the reaction solution is PH-PHENED with an aqueous inorganic alkali (e.g., sodium hydroxide, potassium hydroxide, etc.) solution.
is about 11 or higher and distilled off under reduced pressure.
このようにして得られるL−アスコルビン酸−
2−リン酸エステルを含有する水溶液を強酸性に
するには、たとえば強酸性の鉱酸(例えば塩酸、
硫酸、硝酸等)を使用するが、取扱いの面から塩
酸の使用が好ましい。上記水溶液の強酸性とは、
PH約2以下をいい、さらに好ましくはPH約1以下
をいう。 L-ascorbic acid obtained in this way
To make an aqueous solution containing 2-phosphate ester strongly acidic, for example, use a strongly acidic mineral acid (e.g. hydrochloric acid,
sulfuric acid, nitric acid, etc.), but from the viewpoint of handling, it is preferable to use hydrochloric acid. What is the strong acidity of the above aqueous solution?
It refers to a pH of about 2 or less, more preferably a pH of about 1 or less.
本発明の方法で用いられる活性炭としては、特
に限定されないが、たとえば直径15μ以下の細孔
の全細孔容積1c.c./g以上、直径300Å以下の細
孔の全細孔容積0.6c.c./g以上、直径300Å以下の
細孔の平均細孔直径20Å以上の細孔特性を有する
活性炭が挙げられる。 The activated carbon used in the method of the present invention is not particularly limited, but for example, the total pore volume of pores with a diameter of 15 μ or less is 1 c.c./g or more, and the total pore volume of pores with a diameter of 300 Å or less is 0.6 cc/g. Examples include activated carbon having pore characteristics of 20 Å or more and an average pore diameter of 20 Å or more.
上記細孔特性のうち、直径15μ以下の細孔の全
細孔容積は、たとえば水銀圧入法、窒素ガス吸着
法〔慶伊富長:吸着、第95〜113頁(1967)、共立
出版〕などの方法によつて測定される。直径300
Å以下の細孔の全細孔容積については、たとえば
窒素ガス吸着法(前記文献に記載された方法)な
どの方法によつて測定される。また、直径300Å
以下の細孔の平均細孔直径とは、直径300Å以下
の細孔を円筒形と仮定し、この細孔容積と窒素ガ
ス吸着等温線からBET式(前記文献に記載され
た方法)により計算される比表面積とから次式に
よつて計算される値である。 Among the above pore characteristics, the total pore volume of pores with a diameter of 15μ or less can be determined by, for example, mercury intrusion method, nitrogen gas adsorption method [Keii Tominaga: Adsorption, pp. 95-113 (1967), Kyoritsu Shuppan], etc. It is measured by the method of diameter 300
The total pore volume of pores of Å or less is measured, for example, by a method such as a nitrogen gas adsorption method (method described in the above-mentioned document). Also, the diameter is 300Å
The average pore diameter of the pores below is calculated by the BET formula (method described in the above literature) from the pore volume and nitrogen gas adsorption isotherm, assuming that the pores with a diameter of 300 Å or less are cylindrical. This value is calculated from the specific surface area by the following formula.
平均細孔直径=4×細孔容積/比表面積
(注)この場合の細孔容積とは、直径300Å以下
の細孔の全細孔容積をいう。 Average pore diameter = 4 x pore volume/specific surface area (Note) The pore volume in this case refers to the total pore volume of pores with a diameter of 300 Å or less.
上記のような特定の細孔特性を有する活性炭
は、たとえば木材片、ノコクズ、果実穀(ヤシガ
ラ)などの木質原料を塩化亜鉛、燐酸、塩化カル
シウムなどの薬品に浸漬し、約600〜700℃で焼成
した後、たとえば塩酸などの酸によつて添加薬品
類を脱離、洗浄することにより得られる。 Activated carbon with specific pore characteristics as described above is produced by soaking wood materials such as wood chips, sawdust, and fruit grains (coconut shell) in chemicals such as zinc chloride, phosphoric acid, and calcium chloride, and heating them at approximately 600 to 700°C. After firing, it is obtained by removing added chemicals and washing with an acid such as hydrochloric acid.
活性炭の形状は、粉末状あるいは顆粒状のいず
れでもよいが、なかでも顆粒状のものが好まし
く、たとえば8〜250メツシユの粒度のものが全
体の90%以上含有するものが好ましい。なお、上
記のメツシユは、日本工業規格(JIS)の規準に
よる。 The activated carbon may be in the form of powder or granules, but granules are preferred, and for example, 90% or more of the activated carbon has a particle size of 8 to 250 mesh. Note that the above mesh is based on the standards of Japanese Industrial Standards (JIS).
上記活性炭の具体例としては、たとえばクロマ
ト用特製白鷺、粒状白鷺L、粒状白鷺W(いずれ
も武田薬品工業株式会社製)、カルゴン
(CALGON,Calgon Cooporation製、米国)等
が挙げられる。 Specific examples of the activated carbon include Special Shirasagi for chromatography, Granular Shirasagi L, Granular Shirasagi W (all manufactured by Takeda Pharmaceutical Co., Ltd.), Calgon (CALGON, manufactured by Calgon Cooporation, USA), and the like.
上記の水溶液を活性炭カラムに接触させるに
は、カラムに活性炭を充填し、水を満たしてカラ
ムを調整し、これに該水溶液を通すことにより行
なわれる。該水溶液を通す速度は、通常行なわれ
る方法に従えばよいが、たとえば、1時間当り充
填した活性炭溶量の0.5〜2倍量程度、好ましく
は1倍量程度の流量で通すのがよい。温度は約5
〜20℃である。 The above aqueous solution is brought into contact with an activated carbon column by filling a column with activated carbon, filling the column with water to prepare the column, and passing the aqueous solution through the column. The rate at which the aqueous solution is passed may be according to a commonly used method, but it is preferable to pass the solution at a flow rate of about 0.5 to 2 times, preferably about 1 time, the amount of dissolved activated carbon charged per hour. The temperature is about 5
~20℃.
このようにして、L−アスコルビン酸−2−リ
ン酸エステルが活性炭に吸着される。 In this way, L-ascorbic acid-2-phosphate is adsorbed onto activated carbon.
活性炭カラムに吸着されたL−アスコルビン酸
−2−リン酸エステルは、水性溶媒で溶出され
る。該水性溶媒とは、水を基本とした水溶液をい
う。 The L-ascorbic acid-2-phosphate ester adsorbed on the activated carbon column is eluted with an aqueous solvent. The aqueous solvent refers to an aqueous solution based on water.
該水性溶媒の具体例としては、たとえば水溶性
有機溶媒(例、メタノール、エタノール、アセト
ン、イソブタノール、イソプロピルアルコール
等)の水溶液、塩基性物質(例、水酸化ナトリウ
ム、水酸化カリウム、アンモニア、ジメチルアミ
ン、ジエチルアミン等)の水溶液、無機塩類
(例、塩化ナトリウム、リン酸アンモニア、塩化
アンモニウム等)の水溶液、あるいはこれらの混
合物などが挙げられる。 Specific examples of the aqueous solvent include aqueous solutions of water-soluble organic solvents (e.g., methanol, ethanol, acetone, isobutanol, isopropyl alcohol, etc.), basic substances (e.g., sodium hydroxide, potassium hydroxide, ammonia, dimethyl Examples include aqueous solutions of amines, diethylamine, etc.), aqueous solutions of inorganic salts (eg, sodium chloride, ammonium phosphate, ammonium chloride, etc.), and mixtures thereof.
該塩基性物質または無機塩類の水溶液のPHは、
約7〜9とするのが好ましい。このPH範囲にする
ためには、たとえば塩化ナトリウムの場合は所要
量の水酸化ナトリウム水溶液を塩酸で、リン酸ア
ンモニウムもしくは塩化アンモニウムの場合は所
要量の25%アンモニア水をリン酸もしくは塩酸で
それぞれ調整する。また該水溶性有機溶媒の場合
は5〜20%程度の濃度の水溶液そのままが使用出
来る。 The pH of the aqueous solution of the basic substance or inorganic salt is
Preferably it is about 7-9. To achieve this pH range, for example, in the case of sodium chloride, adjust the required amount of sodium hydroxide aqueous solution with hydrochloric acid, and in the case of ammonium phosphate or ammonium chloride, adjust the required amount of 25% ammonia water with phosphoric acid or hydrochloric acid. do. Further, in the case of the water-soluble organic solvent, an aqueous solution having a concentration of about 5 to 20% can be used as it is.
溶出する温度は、約5〜30℃が好ましい。ま
た、溶出に用いられる水性溶媒の使用量は、活性
炭の容量に対して約1.5〜2.5倍量(容量)が一般
的である。 The elution temperature is preferably about 5 to 30°C. Further, the amount of the aqueous solvent used for elution is generally about 1.5 to 2.5 times the amount (volume) of the activated carbon.
得られた溶出液は、目的物を採取する前に、
種々の適宜の処理を行なつてもよい。たとえば、
溶出溶媒として水溶性有機溶媒の水溶液以外の場
合、これらの塩基性物質および陽イオンを除くた
めに、強酸性イオン交換樹脂〔例えば、ダイヤイ
オンSK−110(三菱化成株式会社製)〕に通し、脱
塩するのが好ましい。 The obtained eluate is processed before collecting the target substance.
Various appropriate treatments may be performed. for example,
If the elution solvent is not an aqueous solution of a water-soluble organic solvent, in order to remove these basic substances and cations, pass it through a strongly acidic ion exchange resin [e.g., Diaion SK-110 (manufactured by Mitsubishi Kasei Corporation)]. Desalting is preferred.
次に、目的物を塩とするのが好ましい。塩とし
ては、たとえばマグネシウム塩、カルシウム塩、
ナトリウム塩、カリウム塩などが挙げられる。該
塩を形成する方法としては、たとえば、マグネシ
ウム塩を得る場合には前記の脱塩液を酸化マグネ
シウムで中和すればよい。また、カルシウム塩を
得るには塩化カルシウムあるいは水酸化カルシウ
ムを、ナトリウム塩を得るには水酸化ナトリウム
を、カリウム塩を得るには水酸化カリウムを用い
上記と同様に処理すればよい。 Next, it is preferable to use a salt as the target object. Examples of salts include magnesium salts, calcium salts,
Examples include sodium salts and potassium salts. As a method for forming the salt, for example, in the case of obtaining a magnesium salt, the desalination solution described above may be neutralized with magnesium oxide. Further, calcium chloride or calcium hydroxide may be used to obtain a calcium salt, sodium hydroxide may be used to obtain a sodium salt, and potassium hydroxide may be used to obtain a potassium salt in the same manner as above.
さらに、必要により着色成分を除去するための
工程に付してもよい。該着色成分の除去工程とし
ては、たとえば、活性炭をつめたカラムに付し、
着色成分を活性炭に吸着除去することにより行な
われる。該活性炭としては、たとえば前記したも
のと同様のものが挙げられる。 Furthermore, if necessary, it may be subjected to a step for removing colored components. The coloring component removal step includes, for example, applying to a column filled with activated carbon,
This is done by adsorbing and removing colored components on activated carbon. Examples of the activated carbon include those similar to those described above.
脱色用活性炭カラムに付す液の特性としては、
中性ないし弱アルカリ性が好ましく、具体的には
PH約6〜10、さらに好ましくはPH約6〜7が挙げ
られる。このような液性に調整する方法として
は、たとえば、鉱酸(塩酸、硫酸、硝酸等)およ
び有機酸(酢酸等)があげられるが、特に塩酸が
好ましい。 The characteristics of the liquid applied to the decolorizing activated carbon column are as follows:
Neutral or slightly alkaline is preferable, specifically
A pH of about 6-10, more preferably a pH of about 6-7. Examples of methods for adjusting the liquid properties include mineral acids (hydrochloric acid, sulfuric acid, nitric acid, etc.) and organic acids (acetic acid, etc.), with hydrochloric acid being particularly preferred.
上記の液をカラムに通過させるときの温度は、
約10〜30℃が好ましい。得られた流出液、および
水をさらに通過させて得られた流出液を採取す
る。 The temperature when passing the above liquid through the column is
About 10-30°C is preferred. The resulting effluent and the resulting effluent from further passage of water are collected.
このようにして得られた目的物を含有する液を
通常行なわれる濃縮工程、晶出工程に付す。該濃
縮は、たとえば減圧濃縮などの方法が採用され
る。晶出工程としては、たとえば、アルコール類
(例、メタノール、エタノール)またはアセトン
などを添加することにより行なわれる。 The solution containing the target product thus obtained is subjected to a conventional concentration step and crystallization step. For the concentration, a method such as vacuum concentration is employed, for example. The crystallization step is carried out, for example, by adding alcohols (eg, methanol, ethanol) or acetone.
本発明の精製法により、目的とするL−アスコ
ルビン酸−2−リン酸エステルを高純度、高収率
で精製することができ、しかも、着色がほとんど
認められない製品を得ることができる。 By the purification method of the present invention, the target L-ascorbic acid-2-phosphate ester can be purified with high purity and high yield, and a product with almost no coloration can be obtained.
本精製法で得られた製品は、再結晶操作を必要
とせず、高速液体クロマトグラフイーによる測定
では99%以上の高純度である。また本精製法によ
ると、高回収率で精製される。 The product obtained by this purification method does not require recrystallization and has a high purity of over 99% as measured by high performance liquid chromatography. Moreover, according to this purification method, purification is achieved with a high recovery rate.
以下に実施例を挙げて本発明をさらに具体的に
説明する。なお、溶液のパーセントはとくにこと
わりのないかぎり、重量/容量パーセントを表わ
す。 The present invention will be explained in more detail with reference to Examples below. Note that the percentage of the solution represents the weight/volume percentage unless otherwise specified.
実施例 1
純水242ml、ピリジン60.6gおよびイソプロピ
リデンアスコルビン酸(以下、「IPA」と略称す
る)30gを混合溶解し、0〜10℃に冷却後60%水
酸化カリウム水溶液を加えてPHを約13に調整し
た。次にこれにテトラクロルピロリン酸(以下
「TCPP」と略称する。)30gと60%水酸化カリウ
ム水溶液とを滴下しながら0〜10℃で反応した。
滴下終了後、ピリジンを減圧下に留去し、塩酸を
加えてPHを約0.5に調整した。Example 1 242 ml of pure water, 60.6 g of pyridine, and 30 g of isopropylidene ascorbic acid (hereinafter abbreviated as "IPA") were mixed and dissolved, and after cooling to 0 to 10°C, 60% aqueous potassium hydroxide solution was added to adjust the pH to approximately Adjusted to 13. Next, 30 g of tetrachloropyrophosphoric acid (hereinafter abbreviated as "TCPP") and a 60% aqueous potassium hydroxide solution were added dropwise to the mixture to react at 0 to 10°C.
After the dropwise addition was completed, pyridine was distilled off under reduced pressure, and hydrochloric acid was added to adjust the pH to about 0.5.
活性炭(クロマト用特製白鷺)200gを充填し、
水を満したカラムに上記のPHを約0.5に調整した
液をSV≒1で流し、更に約1の4%塩酸を流
した。次いでリン酸53g,25%アンモニア水70g
および水1900gの混合物2(PH約8)を流して
L−アスコルビン酸−2−リン酸エステルを含む
部分 約0.9を溶出した。溶出液を300mlの強酸
性イオン交換樹脂(ダイヤイオンSK−110)を通
して脱アンモニアを行い流出液を採取し、その液
に酸化マグネシウム26.4gを加えてL−アスコル
ビン酸−2−リン酸エステルをマグネシウム塩と
すると共に不用のリン酸をリン酸マグネシウムと
して沈澱させた。沈澱物を過して除去後、活性
炭(クロマト用特製白鷺)20gを充填させたカラ
ムに上記L−アスコルビン酸−2−リン酸エステ
ルを含む液をSV≒10で通過させて得られた流出
液および更に水200mlを通じて得られた流出液を
採取した。次にこれらの流出液を合し、これを約
25mlまで減圧下濃縮し、濃縮液に粉末活性炭(白
鷺A、武田薬品工業株式会社製)1.5gを加えて、
10分撹拌後過し、液に90%メタノールを510
ml滴下すると結晶が析出した。析出した結晶を
取し、乾燥するとL−アスコルビン酸−2−リン
酸エステルマグネシウム塩の結晶35.0gが得られ
た。このものは、ほとんど着色が認められなかつ
た。リン酸化反応液からの回収率は86%であつ
た。尚、このものの 高速液体クロマトグラフイ
ーの面積比による含量は、乾物換算で99.3%であ
つた。 Filled with 200g of activated carbon (special Shirasagi for chromatography),
The above solution adjusted to a pH of about 0.5 was passed through a column filled with water at a SV≈1, and then 4% hydrochloric acid at a pH of about 1 was passed through the column. Next, 53g of phosphoric acid, 70g of 25% ammonia water
A mixture 2 containing 1,900 g of water and 1900 g of water (PH of about 8) was flowed to elute a portion containing L-ascorbic acid-2-phosphate ester of about 0.9. The eluate was passed through 300 ml of a strongly acidic ion exchange resin (Diaion SK-110) to remove ammonia and the effluent was collected, and 26.4 g of magnesium oxide was added to the solution to convert L-ascorbic acid-2-phosphate to magnesium. In addition to making a salt, unnecessary phosphoric acid was precipitated as magnesium phosphate. After filtering and removing the precipitate, the liquid containing the above L-ascorbic acid-2-phosphate was passed through a column packed with 20 g of activated carbon (special Shirasagi for chromatography) at SV≒10, resulting in an effluent. And the resulting effluent was collected through another 200 ml of water. These effluents are then combined and reduced to approx.
Concentrate under reduced pressure to 25 ml, add 1.5 g of powdered activated carbon (Shirasagi A, Takeda Pharmaceutical Co., Ltd.) to the concentrated liquid,
After stirring for 10 minutes, filter and add 90% methanol to the liquid.
When ml was added dropwise, crystals precipitated. The precipitated crystals were collected and dried to obtain 35.0 g of L-ascorbic acid-2-phosphate magnesium salt crystals. Almost no coloring was observed in this product. The recovery rate from the phosphorylation reaction solution was 86%. The content of this product based on the area ratio measured by high performance liquid chromatography was 99.3% on a dry matter basis.
元素分析値(%):
C12H12O18P2Mg3・12H2Oとして
理論値 C18.12 H4.56 P7.79
Mg9.17
測定値 C18.00 H4.63 P7.33
Mg9.04
上記の性状、赤外部吸収スペクトル(IR)お
よび紫外部吸収スペクトル(UV)は、ケミカ
ル・アンド・フアーマシユーテイカル・ビユーレ
チン第17巻、381頁(1969年)に記載の値と一致
した(なお、この文献記載のアスコルビン酸−3
−リン酸エステルは、ケミカル・アンド・フアー
マシユーテイカル・ビユーレチン第19巻、No.7、
第1433頁(1971年)および同第30巻、No.3、第
1024頁(1982年)から、アスコルビン酸−2−リ
ン酸エステルである。)。Elemental analysis value (%): C 12 H 12 O 18 P 2 Mg 3・12H 2 O Theoretical value C18.12 H4.56 P7.79 Mg9.17 Measured value C18.00 H4.63 P7.33 Mg9.04 The above properties, infrared absorption spectrum (IR) and ultraviolet absorption spectrum (UV) were consistent with the values described in Chemical and Pharmaceutical Biuretin Vol. 17, p. 381 (1969). , ascorbic acid-3 described in this literature
- Phosphate esters are listed in Chemical and Pharmaceutical Biuretin Vol. 19, No. 7,
No. 1433 (1971) and Volume 30, No. 3, No.
From page 1024 (1982), ascorbic acid-2-phosphate ester. ).
実施例 2
純水350ml、炭酸カリウム50gおよびIPA30g
を混合溶解し、次いでピリジン62mlを加えた後、
0±2℃に保ちながらオキシ酸化リン45gを滴下
してリン酸化を行つた。反応液に30%カセイソー
ダ水溶液を加えてPHを約11とし、減圧下ピリジン
を留去した。さらに塩酸を加えてPHを約0.5にし、
減圧下アセトンを留去して、実施例1と同様の方
法で処理し、L−アスコルビン酸−2−リン酸エ
ステル・マグネシウム塩29.5gを得た。このもの
は、ほとんど着色が認められなかつた。リン酸化
反応液からの回収率は85%であつた。本品のIR,
UVのデーターは前記文献記載の値と一致し、高
速液体クロマトグラフの面積比による含量は99.1
%を示した。尚、晶出用溶媒としてアセトンを
500mlを使用したものについても同様の結果を得
た。Example 2 350ml of pure water, 50g of potassium carbonate and 30g of IPA
After mixing and dissolving, then adding 62ml of pyridine,
Phosphorylation was carried out by dropping 45 g of phosphorus oxyoxide while maintaining the temperature at 0±2°C. A 30% caustic soda aqueous solution was added to the reaction solution to adjust the pH to about 11, and pyridine was distilled off under reduced pressure. Furthermore, add hydrochloric acid to make the pH about 0.5,
Acetone was distilled off under reduced pressure, and the residue was treated in the same manner as in Example 1 to obtain 29.5 g of L-ascorbic acid 2-phosphate magnesium salt. Almost no coloring was observed in this product. The recovery rate from the phosphorylation reaction solution was 85%. IR of this product,
The UV data is consistent with the value described in the above literature, and the content according to the area ratio of high performance liquid chromatography is 99.1.
%showed that. In addition, acetone is used as a solvent for crystallization.
Similar results were obtained using 500ml.
実施例 3
実施例1の方法において、TCPPの代りにオキ
シ塩化リンを使用してIPAをリン酸化したものを
実施例1と同様の方法で精製し、L−アスコルビ
ン酸−2−リン酸エステル・マグネシウム塩34.0
gを得た。純度99.0%。このものは、ほとんど着
色が認められなかつた。本品のIPおよびUVは前
記文献記載の値と一致した。Example 3 In the method of Example 1, IPA was phosphorylated using phosphorus oxychloride instead of TCPP, and it was purified in the same manner as in Example 1 to obtain L-ascorbic acid-2-phosphate ester. Magnesium salt 34.0
I got g. Purity 99.0%. Almost no coloring was observed in this product. The IP and UV values of this product matched the values described in the above literature.
リン酸化反応液からの回収率は84%であつた。The recovery rate from the phosphorylation reaction solution was 84%.
実施例 4
実施例1と同様の方法でリン酸化反応をし、実
施例1と同様の方法で活性炭(クロマト用特製白
鷺)200mlにL−アスコルビン酸−2−リン酸エ
ステルを吸着させた。約4%塩酸水溶液1を通
して活性炭を洗浄し、次いで20%イソプロピルア
ルコール水溶液2をS≒1で通じ、L−アスコ
ルビン酸−2−リン酸エステルを含む部分を採取
した。ついで、実施例1と同様の方法で処理し、
L−アスコルビン酸−2−リン酸エステル・マグ
ネシウム塩の結晶を得た。純度99.3%。リン酸化
反応液からの回収率は85%であつた。Example 4 A phosphorylation reaction was carried out in the same manner as in Example 1, and L-ascorbic acid-2-phosphate was adsorbed on 200 ml of activated carbon (special Shirasagi for chromatography) in the same manner as in Example 1. The activated carbon was washed through approximately 4% aqueous hydrochloric acid solution 1, and then through 20% isopropyl alcohol aqueous solution 2 at S≈1 to collect a portion containing L-ascorbic acid-2-phosphate. Then, treated in the same manner as in Example 1,
Crystals of L-ascorbic acid-2-phosphate magnesium salt were obtained. Purity 99.3%. The recovery rate from the phosphorylation reaction solution was 85%.
このものは、ほとんど着色が認められなかつた。
この結晶のIRおよびUVは、前記文献記載の値と
一致した。Almost no coloring was observed in this product.
The IR and UV of this crystal matched the values described in the above literature.
実施例 5
実施例1と同様の方法でリン酸化および炭末ク
ロマトグラフイー用カラムへ吸着を行なつた後、
約4%塩酸水溶液につづいて、塩化アンモニウム
50gを水1900mlに溶解し、25%アンモニウムでPH
10にした液を流した。流出液においてL−アスコ
ルビン酸−2−リン酸エステルを含む画分約1.5
を採取し、以下、実施例1と同様の脱アンモニ
ア、酸化マグネシウム中和、メタノール晶出の操
作を行ない、L−アスコルビン酸−2−リン酸エ
ステル・マグネシウム塩を得た。純度99.2%。こ
のものは、ほとんど着色が認められなかた。リン
酸化反応液からの回収率は83%であつた。このも
ののIRおよびUVは前記文献記載の値と一致し
た。Example 5 After phosphorylation and adsorption to a column for carbon powder chromatography in the same manner as in Example 1,
About 4% aqueous hydrochloric acid solution, followed by ammonium chloride
Dissolve 50g in 1900ml of water and adjust the pH with 25% ammonium.
I poured the solution at 10. Approximately 1.5 fractions containing L-ascorbic acid-2-phosphate in the effluent
was collected, and the same operations as in Example 1 were performed, including deammonization, neutralization of magnesium oxide, and methanol crystallization, to obtain L-ascorbic acid-2-phosphate magnesium salt. Purity 99.2%. Almost no coloring was observed in this product. The recovery rate from the phosphorylation reaction solution was 83%. The IR and UV values of this product matched the values described in the above literature.
Claims (1)
含有する強酸性の水溶液をカラムにつめた活性炭
に接触させてL−アスコルビン酸−2−リン酸エ
ステルを吸着させ、次いで水性溶媒で溶出するこ
とを特徴とするL−アスコルビン酸−2−リン酸
エステルの精製法。1 A strongly acidic aqueous solution containing L-ascorbic acid-2-phosphate is brought into contact with activated carbon packed in a column to adsorb L-ascorbic acid-2-phosphate, and then eluted with an aqueous solvent. A characterized method for purifying L-ascorbic acid-2-phosphate.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16062682A JPS5951293A (en) | 1982-09-14 | 1982-09-14 | Purification of l-ascorbic acid-2-phosphoric acid ester |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16062682A JPS5951293A (en) | 1982-09-14 | 1982-09-14 | Purification of l-ascorbic acid-2-phosphoric acid ester |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5951293A JPS5951293A (en) | 1984-03-24 |
| JPH0261959B2 true JPH0261959B2 (en) | 1990-12-21 |
Family
ID=15718993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP16062682A Granted JPS5951293A (en) | 1982-09-14 | 1982-09-14 | Purification of l-ascorbic acid-2-phosphoric acid ester |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5951293A (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3909198A1 (en) * | 1989-03-21 | 1990-09-27 | Basf Ag | METHOD FOR THE PRODUCTION OF ASCORBIN ACID-2-PHOSPHATE AND 5,6-ISORPROPYLIDENE-ASCORBIN ACID AS A BASE PRODUCT |
| US5516919A (en) * | 1994-04-28 | 1996-05-14 | Wako Pure Chemical Industries, Ltd. | Process for producing ascorbic acid derivative |
| ATE228525T1 (en) * | 1999-06-07 | 2002-12-15 | Hoffmann La Roche | METHOD FOR CLEANING L-ASCORBYL 2-MONOPHOSPHATE |
| JP2012140330A (en) * | 2010-12-28 | 2012-07-26 | Tosoh Corp | Method for purifying water soluble phosphoric ester |
-
1982
- 1982-09-14 JP JP16062682A patent/JPS5951293A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5951293A (en) | 1984-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0245637B2 (en) | ||
| US20140335202A1 (en) | Iron Sulfate-Based Phosphate Adsorbent | |
| JPH0439476B2 (en) | ||
| JPS5951293A (en) | Purification of l-ascorbic acid-2-phosphoric acid ester | |
| JPH0645626B2 (en) | How to collect ceftazidime | |
| JP4130177B2 (en) | Method for producing high purity riboflavin-5'-phosphate sodium salt | |
| GB2039486A (en) | Ferric salt of fructose-1,6-diphosphate method for producing same and for using same in the preparation of the fructose-1,6-diphosphate | |
| JPS62103075A (en) | Method of purifying l-ascorbic acid | |
| EP0679655B1 (en) | Process for producing ascorbic acid derivatives | |
| CN1159325C (en) | Method for purifying L-ascorbic acid 2-monophosphate | |
| JPS6377890A (en) | Purifying method for l-ascorbic acid-2-phosphate | |
| JP3840672B2 (en) | Method for producing ascorbic acid derivative | |
| JPH0218906B2 (en) | ||
| KR940007418B1 (en) | L-ascorbyl-2-phosphate ester salt derivative and preparation method thereof | |
| JP2877366B2 (en) | Method for producing crystalline L-ascorbic acid-2-phosphate sodium salt | |
| KR910008733B1 (en) | Process for the preparation of l-ascorbic acid-2-phosphoric acid ester magnesium salt | |
| JP3117949B2 (en) | Crystals of L-ascorbic acid-2-phosphate sodium salt | |
| CS235331B2 (en) | Method of cephoperazone's crystalline salt production | |
| JP3378847B2 (en) | Crystals of L-ascorbic acid-2-phosphate sodium salt | |
| JPH062580B2 (en) | Boehmite-like aluminum hydroxide, its production method and oral phosphate adsorbent containing it | |
| JPS6337635B2 (en) | ||
| KR940007419B1 (en) | Method for Purifying L-Ascorbyl-2-Phosphate Magnesium with High Purity | |
| JPH0559917B2 (en) | ||
| US5783688A (en) | Purification of 3'-FDDU and resultant compositions | |
| JPH0834791A (en) | Production of ascorbic-2-phosphoric ester |